Back

Polysubstance use: Delay discounting in relationship to remission

Quddos, F.; Tomlinson, D.; Fontes, R.; Tegge, A.; Bickel, W.

2025-10-02 addiction medicine
10.1101/2025.10.01.25337100 medRxiv
Show abstract

BackgroundRemission from substance use disorders (SUDs) is typically conceptualized as an all-or-none phenomenon. Here, we present a novel construct: proportion of remission (PrR; i.e., the proportion of substances an individual is in remission from relative to lifetime SUD history), a continuous construct that may better capture progress towards recovery in polysubstance use. MethodsIndividuals (n= 2,417) in recovery from SUDs were recruited from International Quit and Recovery Registry (IQRR). Individuals completed a $1000 adjusting amount delay discounting (DD) task, and questions about current and past substance use over the past 12 months and lifetime. We estimated a series of single-level binomial regressions models using PrR as the independent variable and DD, maximum time in recovery, and maximum quit time as dependent variables. In addition, we performed a moderated mediation analysis to understand the relationship between PrR and recovery variables. ResultsWe report that DD, maximum time in recovery, and maximum quit time significantly predicted PrR in individuals with a history of polysubstance use. Further, we found that the relationship between maximum time in recovery and PrR was mediated by the maximum quit time across substances and differed by varying levels of DD. ConclusionResults suggest that longer quit time of any substance is related to improved recovery outcomes, particularly for individuals with low discounting rates. Together, interventions that focus on harm reduction and/or those that modulate DD may lead to improved clinical outcomes (including quit time and PrR) in individuals with a history of polysubstance use.

Matching journals

The top 1 journal accounts for 50% of the predicted probability mass.

1
Drug and Alcohol Dependence
37 papers in training set
Top 0.1%
51.4%
50% of probability mass above
2
Addiction
25 papers in training set
Top 0.1%
10.0%
3
International Journal of Drug Policy
11 papers in training set
Top 0.1%
4.3%
4
Addiction Biology
47 papers in training set
Top 0.3%
4.3%
5
JAMA Network Open
127 papers in training set
Top 0.9%
3.6%
6
Frontiers in Psychiatry
83 papers in training set
Top 2%
2.1%
7
Translational Psychiatry
219 papers in training set
Top 2%
1.9%
8
The British Journal of Psychiatry
21 papers in training set
Top 0.5%
1.8%
9
Computational Psychiatry
12 papers in training set
Top 0.1%
1.8%
10
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 0.9%
1.7%
11
PLOS ONE
4510 papers in training set
Top 55%
1.6%
12
Addiction Neuroscience
17 papers in training set
Top 0.4%
1.3%
13
Psychological Medicine
74 papers in training set
Top 1%
0.9%
14
American Journal of Psychiatry
20 papers in training set
Top 0.4%
0.9%
15
Neuropsychopharmacology
134 papers in training set
Top 2%
0.9%
16
Scientific Reports
3102 papers in training set
Top 73%
0.8%
17
Biological Psychiatry
119 papers in training set
Top 2%
0.8%
18
PLOS Medicine
98 papers in training set
Top 4%
0.8%
19
Biological Psychiatry Global Open Science
54 papers in training set
Top 1%
0.8%
20
Psychopharmacology
59 papers in training set
Top 0.7%
0.7%
21
British Journal of Pharmacology
34 papers in training set
Top 0.6%
0.7%
22
Neuroscience & Biobehavioral Reviews
43 papers in training set
Top 1%
0.7%
23
Alcohol, Clinical and Experimental Research
12 papers in training set
Top 0.3%
0.7%
24
Behavior Genetics
15 papers in training set
Top 0.1%
0.7%